Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ipratropium for Exertional Dyspnea in COPD
NCT00807534Phase 2Completed
- Sponsor
- Université Laval
- Start
- Oct 2008
- Primary completion
- Dec 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ipratropium bromide in chronic obstructive pulmonary disease (COPD), sponsored by Université Laval. Started Oct 2008; status: completed.
02
Drugs
ipratropium bromide
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT00807534.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00807534.